Tsfg LLC cut its holdings in CVS Health Co. (NYSE:CVS – Free Report) by 6.3% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 16,800 shares of the pharmacy operator’s stock after selling 1,137 shares during the period. Tsfg LLC’s holdings in CVS Health were worth $754,000 at the end of the most recent quarter.
A number of other institutional investors have also made changes to their positions in CVS. MidAtlantic Capital Management Inc. acquired a new position in shares of CVS Health during the 3rd quarter worth about $25,000. Livelsberger Financial Advisory bought a new stake in CVS Health during the third quarter worth about $31,000. Legacy Investment Solutions LLC acquired a new position in CVS Health during the third quarter valued at approximately $31,000. Reston Wealth Management LLC acquired a new position in shares of CVS Health during the 3rd quarter worth approximately $32,000. Finally, Kathleen S. Wright Associates Inc. bought a new stake in shares of CVS Health during the 3rd quarter worth approximately $33,000. Institutional investors own 80.66% of the company’s stock.
CVS Health Stock Performance
NYSE CVS opened at $51.54 on Tuesday. The firm’s 50 day simple moving average is $51.76 and its 200 day simple moving average is $56.49. The firm has a market capitalization of $64.86 billion, a price-to-earnings ratio of 13.08, a P/E/G ratio of 0.85 and a beta of 0.59. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80. CVS Health Co. has a 1 year low of $43.56 and a 1 year high of $80.75.
CVS Health Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Monday, February 3rd. Investors of record on Thursday, January 23rd will be issued a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 5.16%. The ex-dividend date of this dividend is Thursday, January 23rd. CVS Health’s dividend payout ratio (DPR) is 67.51%.
Analysts Set New Price Targets
A number of equities analysts recently weighed in on CVS shares. Cantor Fitzgerald restated a “neutral” rating and set a $62.00 target price on shares of CVS Health in a report on Tuesday, October 1st. Wells Fargo & Company raised shares of CVS Health from an “equal weight” rating to an “overweight” rating and upped their target price for the company from $60.00 to $66.00 in a report on Monday, November 18th. Evercore ISI boosted their price target on CVS Health from $62.00 to $75.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 8th. Truist Financial cut their price objective on CVS Health from $67.00 to $60.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Finally, Barclays decreased their target price on CVS Health from $75.00 to $71.00 and set an “overweight” rating on the stock in a report on Thursday, November 7th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and thirteen have issued a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $68.71.
Read Our Latest Analysis on CVS
About CVS Health
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
See Also
- Five stocks we like better than CVS Health
- What Investors Need to Know About Upcoming IPOs
- 2 Stocks to Gain From Trump Universal Tariffs on Critical Imports
- Dividend Capture Strategy: What You Need to Know
- Rigetti Computing, Inc.: Buy, Sell, or Hold for 2025
- What Are Dividend Achievers? An Introduction
- Delta Can Fly to New Highs in 2025; Here’s Why
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVS – Free Report).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.